Keywords: sgx, acquires, shire, anticancer, drug, structural, genomix

SGX acquires Shire's anticancer drug

Article | 09 August 2004

Structural GenomiX of the USA has acquired worldwide rights to UK-basedShire Pharmaceuticals' Troxatyl (troxacitabine), an anticancer drug currently in Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Shire

Go to company listing